Mary Elizabeth Henderson - 31 Aug 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: SVP, Technical Operations
Issuer ticker: JAZZ
Reported as of: 31 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 17:38:13 UTC
Prior SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Mary Elizabeth Henderson

Key filing fact

Mary Elizabeth Henderson filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Sep 2026.

Key facts

This page summarizes Mary Elizabeth Henderson's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 17:38.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001989533 Primary reporting owner

Relationship: SVP, Technical Operations
Address: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature: By: /s/Paz Dizon, as attorney in fact For: Mary Elizabeth Henderson
Signature date: 02 Sep 2026

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Tax liability

JAZZ transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.